GlassScriptPhysician profile
Stephanie Tran
NPI 1720590003
$6,094.06
in general payments reported to CMS, 2019-2025
21 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $424 · 2022: $1,894 · 2023: $2,373 · 2024: $1,214 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,577 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,576.94 |
| Education | $199.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,934.74 | 2021-2024 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $1,475.30 | 2021-2025 | Tezspire, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $1,240.84 | 2021-2024 | Nucala, Arexvy, Trelegy Ellipta |
| Jazz Pharmaceuticals INC. | $398.92 | 2021-2023 | |
| Harmony Biosciences LLC | $209.93 | 2023 | Wakix |
| Amgen INC. | $191.77 | 2022-2024 | Tezspire |
| Avadel Cns Pharmaceuticals, LLC | $107.23 | 2023-2024 | Lumryz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.44 | 2022-2023 | Spiriva Respimat |
| Journey Medical Corporation | $65.26 | 2025 | |
| Redhill Biopharma INC. | $62.56 | 2022-2023 | Aemcolo, Talicia, Movantik |
| Axsome Therapeutics, INC. | $60.62 | 2023 | Sunosi |
| Mylan Specialty L.P. | $55.01 | 2022-2024 | Yupelri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.86 | 2022-2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $27.40 | 2023 | |
| Dermavant Sciences, INC. | $25.94 | 2024 | Vtama |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $24.32 | 2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Verrica Pharmaceuticals INC. | $22.97 | 2024 | Ycanth |
| Grifols USA, LLC | $22.13 | 2021 | |
| Sun Pharmaceutical Industries INC. | $20.83 | 2022 | |
| Biofrontera INC. | $18.42 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Philips North America LLC | $14.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.